glp1 tirzepatide side effects vs Semaglutide: Which Weight Loss Medication Works Better? Can you take GLP-1 a

Tirzepatide and semaglutide: Whats the difference

Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, though these medications are often collectively referred to as incretin-based therapies

What This Means for You How the Weight-Loss Pathway Opened Up From Announcement to Live Program On November 6, 2025 , the Trump administration announced agreements with Eli Lilly and Novo Nordisk to expand Medicare coverage of GLP-1 medications for obesity

The most common side effects are gastrointestinal, including nausea (12-24%), diarrhea (13-17%), and vomiting (6-10%)

This may lead to: Missed periods Delayed periods Lighter bleeding Irregular cycles For many women, these changes improve once weight stabilizes and the body adapts

If you're traveling, a portable insulated case with ice packs or a travel cooler maintains the cold chain during transport